Literature DB >> 1548964

The health consequences of smoking. Cancer.

P A Newcomb1, P P Carbone.   

Abstract

Smoking has now been identified as a definite cause of cancer at many sites (Table 2). Of all cancers in the United States, 30% could be prevented if cigarette smoking were eliminated. Organs in direct contact with smoke--the oral cavity, esophagus, lung, and bronchus--are at the greatest risk of malignancy among smokers. As many as 90% of these cancers are attributable to smoking. Organs and tissues distant from smoke are also at some increased risk. Among smokers, rates of cancer of the cervix, pancreas, bladder, kidney, stomach, and hematopoietic tissue are increased 50% to 200% over rates in nonsmokers. Risk of cancer at all sites increases with increasing exposure to cigarette smoke. Cigarette smoke contains potent carcinogens that influence carcinogenesis at both early and late stages. These carcinogens can interact with other exposures, such as alcohol, to synergistically increase the risk of cancer. The adverse carcinogenic effects of cigarette smoking, however, can be reduced for all smokers if tobacco use is stopped. The prevalence of smoking among the US population as a whole has declined from 40% in 1965 to 29% in 1987. This progress against the epidemic of tobacco use has already produced a decrease in the occurrence of the most common tumor among men, lung cancer. Unfortunately, the decline in smoking prevalence and cancer incidence has not occurred equally across US populations. Death rates of lung cancer in women continue to rise, and, based upon current smoking patterns, these rates will continue to increase into the next century. The challenge to physicians and public health workers is compelling and immediate: Abstaining from smoking is the single most effective way to reduce an individual's risk of cancer.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1548964     DOI: 10.1016/s0025-7125(16)30355-8

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  32 in total

1.  Employee stress levels and the intention to participate in a worksite smoking cessation program.

Authors:  W F Chan; C A Heaney
Journal:  J Behav Med       Date:  1997-08

2.  Dynamics of smoking-induced genome-wide methylation changes with time since smoking cessation.

Authors:  Florence Guida; Torkjel M Sandanger; Raphaële Castagné; Gianluca Campanella; Silvia Polidoro; Domenico Palli; Vittorio Krogh; Rosario Tumino; Carlotta Sacerdote; Salvatore Panico; Gianluca Severi; Soterios A Kyrtopoulos; Panagiotis Georgiadis; Roel C H Vermeulen; Eiliv Lund; Paolo Vineis; Marc Chadeau-Hyam
Journal:  Hum Mol Genet       Date:  2015-01-02       Impact factor: 6.150

3.  The Association of Pain With Smoking and Quit Attempts in an Electronic Diary Study of Cancer Patients Trying to Quit.

Authors:  Carrie J Aigner; Paul M Cinciripini; Karen O Anderson; George P Baum; Ellen R Gritz; Cho Y Lam
Journal:  Nicotine Tob Res       Date:  2015-06-02       Impact factor: 4.244

4.  Accounting for increased non-target-disease-specific mortality in decision-analytic screening models for economic evaluation.

Authors:  Björn Stollenwerk; Afschin Gandjour; Markus Lüngen; Uwe Siebert
Journal:  Eur J Health Econ       Date:  2012-12-30

5.  An historical perspective on health-risk awareness and unhealthy behaviour: cigarette smoking in the United States 1949-1981.

Authors:  Andrew J Leidner; W Douglass Shaw; Steven T Yen
Journal:  Health Expect       Date:  2014-07-29       Impact factor: 3.377

Review 6.  Human papillomavirus and bladder cancer.

Authors:  N R Boucher; J B Anderson
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1997

7.  Smoking and risk of sleep-related issues: a systematic review and meta-analysis of prospective studies.

Authors:  Sohrab Amiri; Sepideh Behnezhad
Journal:  Can J Public Health       Date:  2020-03-17

8.  Transcriptomic epidemiology of smoking: the effect of smoking on gene expression in lymphocytes.

Authors:  Jac C Charlesworth; Joanne E Curran; Matthew P Johnson; Harald Hh Göring; Thomas D Dyer; Vincent P Diego; Jack W Kent; Michael C Mahaney; Laura Almasy; Jean W MacCluer; Eric K Moses; John Blangero
Journal:  BMC Med Genomics       Date:  2010-07-15       Impact factor: 3.063

Review 9.  Superficial bladder cancer.

Authors:  R R Hall
Journal:  BMJ       Date:  1994-04-02

10.  Variation in smoking-related lung cancer risk factors by cell type among men in Argentina: a case-control study.

Authors:  S M Pezzotto; R Mahuad; M L Bay; J C Morini; L Poletto
Journal:  Cancer Causes Control       Date:  1993-05       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.